IGF1 and Hypoglycemia: Thus, while the use of higher than physiological concentrations of recombinant human (rh) IGF-1 and insulin in healthy volunteers, showed the lowest and comparable decrease in glucose levels after 30 min from bolus intravenous peptide administration, IGF-1 was only 6% as potent as insulin in the inducing of hypoglycemia [100].